NHS England. Cervical Screening Standards Data Report 2023 to 2024. GOV.UK, 2025. https://www.gov.uk/government/publications/cervical-screening-standards-data-report-2023-to-2024/cervical-screening-standards-data-report-2023-to-2024
Key takeaways
- Cervical cancer risk does not disappear after menopause. Around half of all cervical cancer deaths in the UK occur in women over 50, the age group whose screening attendance is declining.
- The pain and discomfort many women experience during cervical screening after menopause has a clear physiological explanation: declining oestrogen changes vaginal tissue, making speculum insertion more uncomfortable.
- There are practical steps that make a real difference, including using vaginal oestrogen for several weeks before your appointment, which can restore tissue resilience and reduce discomfort significantly.
If you have been putting off your smear test, you are not alone
A UCL qualitative study published in Post Reproductive Health found that around a third of women aged over 50 have found cervical screening painful with age. A previous bad or painful experience featured as a deterrent in five out of six focus groups in a 2019 UCL study in BMC Women's Health. Many women described not attending because they believed they no longer needed it, because the procedure had become uncomfortable, or simply because the memory of a difficult previous experience put them off rebooking.
None of that is weakness, and none of it is unusual. What menopause does to vaginal tissue changes the experience of cervical screening in ways that most women were never warned about, and that most healthcare encounters do not have time to address properly.
The rest of this article is about making that experience better, and making the case for why it is worth doing.
Why cervical screening still matters after menopause
One of the most common reasons women stop attending is the belief that they no longer need screening: they are past the age when it mattered, or they are no longer sexually active, or they feel their risk has passed.
This is a genuinely widespread misconception, and it is worth addressing directly.
Cervical cancer risk does not end at menopause. Research reporting on large observational data suggests that women aged 65 and over remain a higher-risk group for cervical cancer incidence and mortality, with declining immune function and postmenopausal hormonal changes potentially affecting the body's ability to clear high-risk HPV infections. The average age at cervical cancer diagnosis in England is around 50, right in the middle of the perimenopause transition.
UCL researchers have projected that by 2036 to 2040, the peak age for cervical cancer diagnosis in England will shift to the late 50s, for the cohort of women who were too old to receive the HPV vaccine. This is the generation currently being invited for screening. They are the generation for whom attendance matters most.
Non-attendance in this age group is not a minor administrative gap. It is a meaningful public health risk, concentrated in the women who most need protection.
What about not being sexually active?
HPV, the virus that causes almost all cervical cancers, can remain dormant in the body for years after past sexual contact. You do not need to be currently sexually active for HPV to be present, and you do not need to have had many partners. A positive HPV result in cervical screening is not a reflection of anything about your sexual history. It means the virus was detected, and that monitoring is appropriate. Most HPV infections clear on their own; the screening programme exists to catch the ones that do not.
The NHS screening schedule: what you need to know
The NHS invites women for cervical screening from age 25. From 25 to 64, the invitation comes every five years. After 65, you will only be invited if a recent result was abnormal. If you are in that age group and have not kept up with screening in recent years, it is worth speaking to your GP.
Since 2019, the NHS has used HPV-primary screening, meaning the test now looks first for HPV rather than directly for abnormal cells. Understanding what your result means has changed:
- HPV not detected: no further action needed; you will be recalled in the usual timeframe.
- HPV detected, no cell changes: you will be asked to return in one year for a repeat test.
- HPV detected, with cell changes: you will be referred for a colposcopy (a closer look at the cervix) for further assessment.
- Inadequate sample: the cells could not be analysed properly; you will be asked to repeat the test.
That last result is more relevant to this article than most content acknowledges, and there is a separate section on it below.
Post-hysterectomy note: whether you still need cervical screening after a hysterectomy depends on the type of surgery and whether your cervix was removed. Your GP can confirm what applies to you. Do not assume screening is no longer needed without checking.
Why menopause makes cervical screening more uncomfortable, and why this is not your fault
The short version: declining oestrogen changes vaginal and cervical tissue in ways that make the speculum, which was manageable before, genuinely uncomfortable now.
The clinical term for these changes is genitourinary syndrome of menopause (GSM). As oestrogen falls, vaginal tissue becomes thinner, drier, less elastic, and more fragile. The natural lubrication that keeps tissue resilient reduces. The opening to the vagina may narrow slightly. Other symptoms of GSM may include: urinary frequency, urgency, recurrent UTIs and pain during intercourse.
A speculum that presented no problem ten years ago now meets tissue that is more delicate and less accommodating. Pain during insertion, difficulty completing the procedure, and significant discomfort afterwards are all direct physiological consequences of these changes. They are not anxiety, they are not being dramatic, and they are not something that simply requires gritting your teeth and getting through it.
A 2022 UK cross-sectional study published in the British Journal of General Practice confirmed that speculum-based screening becomes measurably more uncomfortable after menopause, and that postmenopausal anatomy changes make both sampling and insertion more difficult.
The inadequate sample problem: what vaginal atrophy has to do with your results
Here is something almost no consumer-facing content on this topic mentions: vaginal atrophy not only makes the speculum more painful, it makes it harder to collect a good sample.
When vaginal tissue is fragile, the cells do not always transfer cleanly onto the sample brush. The result can be an inadequate sample, meaning the test cannot be properly analysed and needs to be repeated. This adds another appointment, another speculum, and another uncomfortable experience to a process that was already a barrier.
Treating the underlying genitourinary changes is not just about making one appointment more bearable. It reduces the likelihood of having to do it again. For women who find screening genuinely difficult, this is a meaningful practical argument for treating GSM as an ongoing health concern, not just as preparation for a single appointment.
How to make your next cervical screening more manageable
These are specific, practical steps backed by clinical evidence and guidance from NHS organisations and peer-reviewed research.
Use vaginal oestrogen in the weeks before your appointment
Vaginal oestrogen is a topical treatment that helps restore vaginal tissue, making it thicker, more elastic and more hydrated. It is typically used for around two weeks before a cervical screening appointment, which can make speculum insertion significantly more comfortable. Using it for several weeks before a cervical screening appointment can make speculum insertion significantly more comfortable by improving the resilience of the tissue the speculum encounters. A 2024 systematic review in the Annals of Internal Medicine, examining 46 randomised controlled trials, found that compared with placebo or no treatment, vaginal oestrogen meaningfully improves vulvovaginal dryness and related symptoms.
Vaginal oestrogen is a prescription treatment. A Voy specialist can assess whether it is right for you and issue a prescription following a consultation. If you have a personal history of breast cancer or other hormone-sensitive conditions, discuss vaginal oestrogen with a specialist who can assess your individual circumstances.
Tell the nurse or doctor in advance
Let your sample-taker know before the appointment, when booking if possible, that you experience vaginal dryness or discomfort. This allows them to prepare, take extra time, and approach the procedure differently. You will be asked to stop using vaginal oestrogen and any other vaginal preparations, such as lubricants or moisturisers approximately 2 days before your appointment to avoid contamination of the sample.
Ask for a smaller speculum
Speculums come in different sizes. A smaller one is a straightforward request and is routinely available. You do not need to explain at length. "I'd prefer a smaller speculum if possible" is enough.
Ask for lubricant
Water-based lubricant can be applied to the speculum to reduce friction significantly. Some sample-takers use it automatically; others do not. Ask for it explicitly.
Try a different position
Lying slightly on your side, with your knees drawn up, can be more comfortable for some women than the standard position. Ask your sample-taker if this is possible.
Keep more of your clothes on
You only need to remove clothing from the waist down. Wearing a long top or a skirt means you can keep it on throughout, which many women find makes the experience feel less exposed.
“Know you are in control- You can ask the sample-taker to stop at any point. You can take a breath and restart. You can rebook if the appointment needs to stop before completion. You are not obligated to push through to the point of pain.”

Common questions about cervical screening and menopause
Do I still need screening if I'm not sexually active?
Yes. HPV can remain dormant in the body for years after past sexual contact. Current sexual activity does not determine your HPV status, and screening looks for changes that can develop regardless of whether you are currently sexually active.
What does a positive HPV result actually mean?
It means HPV was detected in your sample. It is not a cancer diagnosis. Most HPV infections clear naturally; the purpose of further investigation is to monitor whether any cell changes are developing. HPV is extremely common: most sexually active people will have it at some point in their lives, often without knowing. A positive result is not a reflection of anything about your sexual history.
What if my last result was normal?
Cervical screening looks for new changes each time. A normal result in the past does not mean you are protected indefinitely. Attending at the recommended intervals is what provides ongoing protection.
What symptoms should I report between screenings?
Any vaginal bleeding after menopause (including spotting), unusual discharge, or pelvic pain should be reported to your GP regardless of where you are in the screening cycle. These are not necessarily signs of anything serious, but they should always be assessed promptly.
Getting the support to make screening easier
If vaginal dryness and discomfort are making cervical screening feel impossible, the most useful thing is not a different technique at the appointment. It is treating the underlying cause.
Genitourinary syndrome of menopause is common, very treatable, and very underdiagnosed. Many women live with vaginal dryness, discomfort, and urinary changes for years without knowing that an effective prescription treatment exists. Treating it improves daily life, not just one appointment every five years.
88% of Voy members felt more hormonally balanced at three months, compared to 62% receiving standard care (presented at The Menopause Society 2025, forthcoming in Climacteric). Getting the right menopause support changes the experience of being in your body during this stage of life, and that includes the experience of necessary healthcare appointments.
Voy's menopause consultations are 45 minutes with BMS-trained (British Menopause Society) specialists who have the time to take a full history, discuss vaginal oestrogen, assess whether it is appropriate for your circumstances, and build a broader menopause treatment plan around you. If cervical screening has become something you dread or avoid, that is a conversation worth having.




















